Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
61.65
-1.68 (-2.65%)
At close: Oct 6, 2026, 4:00 PM EDT
61.13
-0.52 (-0.84%)
Pre-market: Oct 7, 2026, 5:17 AM EDT
Disc Medicine Market Cap
Disc Medicine has a market cap or net worth of $2.37 billion as of October 6, 2026. Its market cap has increased by 0.45% in one year.
Market Cap
2.37B
Enterprise Value
1.71B
1-Year Change
0.45%
Ranking
Category
Stock Price
$61.65
ChartMarket Cap Chart
Since December 30, 2022, Disc Medicine's market cap has increased from $336.60M to $2.37B, an increase of 603.18%. That is a compound annual growth rate of 67.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 2.37B | -21.04% |
| Dec 31, 2025 | 3.00B | 58.89% |
| Dec 31, 2024 | 1.89B | 35.31% |
| Dec 29, 2023 | 1.39B | 314.24% |
| Dec 30, 2022 | 336.60M | - |
| Dec 30, 2022 | 336.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NewAmsterdam Pharma Company | 2.73B |
| Beam Therapeutics | 2.57B |
| Recursion Pharmaceuticals | 2.56B |
| Celldex Therapeutics | 2.56B |
| Immunome | 2.40B |
| Nurix Therapeutics | 2.37B |
| SELLAS Life Sciences Group | 2.35B |
| Harmony Biosciences Holdings | 2.32B |